activity
20082021
most citedA general framework for inference on algorithm-agnostic variable importance

74 citations · 230 across the 14 of their papers we have counts for

collaborators

15 papers

stat.ME2021★ 1 cited

Assessment of Immune Correlates of Protection via Controlled Vaccine Efficacy and Controlled Risk

Peter B. Gilbert, Youyi Fong, Marco Carone

Immune correlates of protection (CoPs) are immunologic biomarkers accepted as a surrogate for an infectious disease clinical endpoint and thus can be used for traditional or provis…

stat.ME2021★ 16 cited

Efficient nonparametric estimation of the covariate-adjusted threshold-response function, a support-restricted stochastic intervention

Lars van der Laan, Wenbo Zhang, Peter B. Gilbert

Identifying a biomarker or treatment-dose threshold that marks a specified level of risk is an important problem, especially in clinical trials. This risk, viewed as a function of…

stat.ME2020★ 26 cited

Efficient nonparametric inference on the effects of stochastic interventions under two-phase sampling, with applications to vaccine efficacy trials

Nima S. Hejazi, Mark J. van der Laan, Holly E. Janes +2

The advent and subsequent widespread availability of preventive vaccines has altered the course of public health over the past century. Despite this success, effective vaccines to…

stat.ME2020★ 74 cited

A general framework for inference on algorithm-agnostic variable importance

Brian D. Williamson, Peter B. Gilbert, Noah R. Simon +1

In many applications, it is of interest to assess the relative contribution of features (or subsets of features) toward the goal of predicting a response -- in other words, to gaug…

stat.AP2019

Ongoing Vaccine and Monoclonal Antibody HIV Prevention Efficacy Trials and Considerations for Sequel Efficacy Trial Designs

Peter B. Gilbert

Four randomized placebo-controlled efficacy trials of a candidate vaccine or passively infused monoclonal antibody for prevention of HIV-1 infection are underway (HVTN 702 in South…

stat.AP2018★ 1 cited

Post-randomization Biomarker Effect Modification in an HIV Vaccine Clinical Trial

Peter B. Gilbert, Bryan S. Blette, Bryan E. Shepherd +1

While the HVTN 505 trial showed no overall efficacy of the tested vaccine to prevent HIV infection over placebo, previous studies, biological theories, and the finding that immune…